when did tirzepatide come out How the weight loss drug is also helping heart failure patients Tirzepatide (Mounjaro): Type 2 Diabetes

Facial laser is not a substitute

What the Latest Clinical Trial Results Show According to publicly reported late-stage trial data: Participants receiving higher doses achieved average weight loss approaching 2530% over approximately 68 weeks Some individuals lost more than 70 pounds during the study period Participants with obesity and knee osteoarthritis also reported significant reductions in joint pain These outcomes exceeded the average weight loss typically reported in clinical trials of currently approved GLP-1 medications

35 Nausea can be addressed in several of different ways: if receiving a titratable GLP-1RA, return to the previous dose or premeal interval that did not cause symptoms (maximal tolerated dose) give a nontitratable GLP-1RA on a full stomach consider antiemetics for intractable symptoms

Yes, regular monitoring is essential, including kidney function tests at baseline and at least annually (more frequently if eGFR is below 60), liver function tests, and HbA1c if you have diabetes

The medication is wearing off late in the weekly cycle Ozempic is once-weekly, but the level in your body is not perfectly flat across all seven days